ScholarIQanswers from OpenAlex

VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome

PaperCitations, authors & open-access status

VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome is a paper indexed in ScholarIQ from OpenAlex.

How many citations does VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome have?

ScholarIQcitation count

VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome has 22 citations in the OpenAlex counts ScholarIQ stores.

When was VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome published?

ScholarIQyear

VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome has 2021 year in the ScholarIQ index.

What is the open-access status of VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome?

ScholarIQoa status

VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome has closed oa status in the ScholarIQ index.

What is the DOI of VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome?

ScholarIQdoi

The DOI for VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome is on the source record.

What is the PMID of VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome?

ScholarIQpmid

The PMID for VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome is on the source record.

What is the OpenAlex record for VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome?

ScholarIQopenalex

The OpenAlex for VX-765 prevents intestinal ischemia-reperfusion injury by inhibiting NLRP3 inflammasome is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial